Waanext Pharmaceutical Llp - Company Profile

It is a pharma limited liability partnership based in Mumbai, Maharashtra, India, established in 2021.
2021 Mumbai, Maharashtra, India Active
Last Updated:
Access Report
About Waanext Pharmaceutical Llp

Waanext Pharmaceutical Llp, a active limited liability partnership, was established on 26 October 2021 in Mumbai, Maharashtra, India. Engaging in drug formulation & development within the pharma sector, it holds LLPIN: AAZ-1996. Registered under ROC Roc Mumbai Ii. It has total obligation of contribution of ₹50.00 K .

Its leadership includes Balwant Singh (Designated Partner), Sandeep Balu Chikhalkar (Designated Partner), Shashikant Satyadev Singh (Designated Partner). Its latest date of accounts and solvency statement 31 March 2025. It is based at Mangeshi Sanskar, B/702, Khadegoliwali, Kalyan, Mumbai, Maharashtra, 421306.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    AAZ-1996

  • Incorporation Date

    26 October 2021

  • Total Obligation of Contribution

    ₹50.00 K

  • ROC Code

    Roc Mumbai Ii

  • Company Status

    Active

Key Metrics
  • Obligation of Contribution ₹ 50.00 K
  • Company Age 4 Year, 5 Months
  • Last Filing with ROC 31 Mar 2025
Company report

Waanext Pharmaceutical Llp

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Waanext Pharmaceutical Llp — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Waanext Pharmaceutical Llp?
Current Designated Partners
Name Designation Appointment Date Status
Balwant Singh Designated Partner 26 Oct 2021 Current
Sandeep Balu Chikhalkar Designated Partner 26 Oct 2021 Current
Shashikant Satyadev Singh Designated Partner 26 Oct 2021 Current
Usha Vinodkumar Shukla Designated Partner 17 Aug 2022 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Waanext Pharmaceutical Llp.

Enhance accessibility to Waanext Pharmaceutical Llp's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Waanext Pharmaceutical Llp revenue growth over time
Waanext Pharmaceutical Llp profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Waanext Pharmaceutical Llp?

Unlock access to Waanext Pharmaceutical Llp's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Waanext Pharmaceutical Llp?

Unlock and access historical data on people associated with Waanext Pharmaceutical Llp, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Waanext Pharmaceutical Llp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Waanext Pharmaceutical Llp's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Waanext Pharmaceutical Llp
Recent Activity within the Organization
  • Statement of Assets & Liabilities

    Progress on Waanext Pharmaceutical Llp has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai Ii. was documented.

  • Annual General Meeting

    Progress on Waanext Pharmaceutical Llp last Annual general meeting of members was held on 31 Mar 2024 as per latest MCA records. was documented.

  • Director Appointment

    The activity Usha Vinodkumar Shukla was appointed as a Designated Partner was appointed as a Designated Partner on 17 Aug 2022 & has been associated with this company since 3 years 7 months . was completed.

  • Director Appointment

    The activity Balwant Singh was appointed as a Designated Partner was appointed as a Designated Partner on 26 Oct 2021 & has been associated with this company since 4 years 5 months . was completed.

  • Director Appointment

    Progress on Sandeep Balu Chikhalkar was appointed as a Designated Partner was appointed as a Designated Partner on 26 Oct 2021 & has been associated with this company since 4 years 5 months . was documented.

  • Director Appointment

    Progress on Shashikant Satyadev Singh was appointed as a Designated Partner was appointed as a Designated Partner on 26 Oct 2021 & has been associated with this company since 4 years 5 months . was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the LLPIN of Waanext Pharmaceutical Llp?

The LLPIN of Waanext Pharmaceutical Llp is AAZ-1996.

Where is Waanext Pharmaceutical Llp headquartered?

Waanext Pharmaceutical Llp is headquartered at Mangeshi Sanskar, B/702, Khadegoliwali, Kalyan, Mumbai, Maharashtra, 421306.

When was Waanext Pharmaceutical Llp incorporated?

Waanext Pharmaceutical Llp was incorporated on 26 October 2021.

Who are the current directors of Waanext Pharmaceutical Llp?

The current directors of Waanext Pharmaceutical Llp are

What is the primary industry of Waanext Pharmaceutical Llp?

The primary industry of Waanext Pharmaceutical Llp is Pharma.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available